Rizatriptan Benzoate Tablet, Orally Disintegrating
Product Images NDC 33342-094

24 FDA label images from Macleods Pharmaceuticals Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 33342-094). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Rizatriptan Structure)

Structure (Rizatriptan Structure)
Chemical structure of rizatriptan benzoate, illustrating the molecular arrangement of its active ingredient components, including the indole and benzoate groups.*
FDA Label Image

Figure-1 (Rizatriptan Figure 1)

Figure-1 (Rizatriptan Figure 1)
A line chart depicting the estimated probability of response over time up to 2 hours post-dose for rizatriptan benzoate tablets 5 mg and 10 mg compared to placebo. The chart shows the response rates increasing from 0% to approximately 40% for placebo, 65% for 5 mg, and 70% for 10 mg tablets.*
FDA Label Image

Figure-2 (Rizatriptan Figure 2)

Figure-2 (Rizatriptan Figure 2)
A line graph depicting the estimated probability of remediation or rescue over 24 hours post-dose for rizatriptan benzoate tablets at 5 mg and 10 mg strengths compared to placebo. The horizontal axis shows hours post-dose, while the vertical axis represents the estimated probability percentage. The graph includes three lines: placebo, 5 mg tablets, and 10 mg tablets, illustrating their respective curves over time.*
FDA Label Image

Figure-3 (Rizatriptan Figure 3)

Figure-3 (Rizatriptan Figure 3)
A line graph showing the estimated probability of response over time in hours post-dose for rizatriptan benzoate orally disintegrating tablets at 5 mg and 10 mg doses compared to placebo. The graph illustrates higher response probabilities for both rizatriptan doses versus placebo, with the 10 mg dose showing the highest response over 2 hours.*
FDA Label Image

Figure-4 (Rizatriptan Figure 4)

Figure-4 (Rizatriptan Figure 4)
A line graph showing the estimated probability of medication or rescue over 24 hours post-dose for rizatriptan benzoate orally disintegrating tablets at 5 mg and 10 mg doses compared to placebo. The y-axis represents the probability percentage, while the x-axis shows hours post-dose from 0 to 24. Three lines chart the progression for placebo, 5 mg, and 10 mg dosage strengths.*
FDA Label Image

Fig-5 (Rizatriptan Figure 5)

Fig-5 (Rizatriptan Figure 5)
A line graph comparing the percentage response over time for Rizatriptan Benzoate Orally Disintegrating Tablets versus Placebo. The x-axis represents hours post stage 2 dose (0.5 to 2.0 hours), and the y-axis shows percent response with 95% confidence intervals. The graph displays increasing response over time for both treatment and placebo, with Rizatriptan showing higher percent values.*
FDA Label Image

111 (Rizatriptan Odt Usp 5mg 1x3s Pack)

111 (Rizatriptan Odt Usp 5mg 1x3s Pack)
Packaging label for Rizatriptan Benzoate Orally Disintegrating Tablets USP 5 mg by Macleods Pharmaceuticals Limited. The label shows the product name, strength (5 mg), dosage form (orally disintegrating tablets), quantity (3 tablets in unit-dose blister pack), manufacturer details including Macleods Pharma USA and Macleods Pharmaceuticals Ltd India, and instructions for opening the blister pack. It includes storage information and a barcode.*
FDA Label Image

Rizatriptan-odt-usp-5mg-3x6s-pack.jpg (Rizatriptan Odt Usp 5mg 3x6s Pack)

Rizatriptan-odt-usp-5mg-3x6s-pack.jpg (Rizatriptan Odt Usp 5mg 3x6s Pack)
Packaging label for Rizatriptan Benzoate Orally Disintegrating Tablets, USP 5 mg from Macleods Pharmaceuticals Limited. The label indicates this prescription oral tablet product contains 18 tablets (3 x 6 Unit-Dose Tablets) and includes instructions for opening the blister pack. The label also notes storage conditions and contains barcode and lot expiration sections.*
FDA Label Image

1 (Rizatriptan Odt Usp 5mg 3x3s Pack)

1 (Rizatriptan Odt Usp 5mg 3x3s Pack)
Packaging label for Rizatriptan Benzoate Orally Disintegrating Tablets, USP 5 mg, manufactured by Macleods Pharmaceuticals Limited. The label includes branding for Macleods Pharma USA, NDC 33342-093-73, and shows a package containing 9 tablets (3 x 3 unit-dose tablets). Instructions for opening the blister pack are illustrated, and storage instructions, dosage information, and phenylketonurics warning are noted on the label.*
FDA Label Image

1 (Rizatriptan Odt Usp 5mg 6x3s Pack)

1 (Rizatriptan Odt Usp 5mg 6x3s Pack)
Packaging label for Rizatriptan Benzoate Orally Disintegrating Tablets, USP 5 mg by Macleods Pharmaceuticals Limited. Tablets package contains 18 tablets (6 x 3 Unit-Dose Tablets). Label includes manufacturer info, dosage instructions, and a barcode. The product is for oral use and prescription only.*
FDA Label Image

Rizatriptan-odt-usp-5mg-2x6s-pack.jpg (Rizatriptan Odt Usp 5mg 2x6s Pack)

Rizatriptan-odt-usp-5mg-2x6s-pack.jpg (Rizatriptan Odt Usp 5mg 2x6s Pack)
Packaging label for Rizatriptan Benzoate Orally Disintegrating Tablets USP 5 mg by Macleods Pharmaceuticals Limited. The label shows the product name, strength (5 mg), dosage form (orally disintegrating tablets), and a 12-tablet package (2 x 6 unit-dose tablets). It includes instructions for opening the blister pack, storage conditions, and manufacturer information for Macleods Pharma USA Inc. and Macleods Pharmaceuticals Ltd., India. The label also features barcodes and space for lot and expiration information.*
FDA Label Image

1 (Rizatriptan Odt Usp 5mg 30s Pack)

1 (Rizatriptan Odt Usp 5mg 30s Pack)
The label for Rizatriptan Benzoate Orally Disintegrating Tablets, USP, 5 mg strength. The label indicates a package containing 30 tablets, manufactured by Macleods Pharmaceuticals Limited and Macleods Pharma USA, Inc. It includes storage instructions, a note on phenylalanine content for phenylketonurics, and a barcode.*
FDA Label Image

1 (Rizatriptan Odt Usp 5mg 200s Pack)

1 (Rizatriptan Odt Usp 5mg 200s Pack)
Label for Rizatriptan Benzoate Orally Disintegrating Tablets, USP 5 mg, by Macleods Pharmaceuticals Limited. The label indicates 200 tablets in the package, with storage instructions and a caution for phenylketonurics regarding phenylalanine content. Manufactured for Macleods Pharma USA, Inc., Princeton, NJ, and by Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India.*
FDA Label Image

555 (Rizatriptan Odt Usp 5mg 12s Pack)

555 (Rizatriptan Odt Usp 5mg 12s Pack)
Label for Rizatriptan Benzoate Orally Disintegrating Tablets, USP 5 mg by Macleods Pharmaceuticals Limited. The label includes dosage strength of 5 mg, package count of 12 tablets, storage instructions, and manufacturer details located in Baddi, Himachal Pradesh, India and Princeton, NJ, USA. The label indicates prescription use only.*
FDA Label Image

889 (Rizatriptan Odt Usp 5mg 18s Pack)

889 (Rizatriptan Odt Usp 5mg 18s Pack)
Label for Rizatriptan Benzoate Orally Disintegrating Tablets USP 5 mg, a prescription human drug in tablet form. The label shows the product name, dosage strength of 5 mg, and packaging quantity of 18 tablets. It includes storage instructions and manufacturer details for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd.*
FDA Label Image

1 (Rizatriptan Odt Usp 10mg 1x3s Packs)

1 (Rizatriptan Odt Usp 10mg 1x3s Packs)
Packaging label for Rizatriptan Benzoate Orally Disintegrating Tablets, USP 10 mg by Macleods Pharmaceuticals Limited. The label includes the product name, dosage strength of 10 mg, and the manufacturer Macleods Pharma USA, Inc. It specifies a package containing 3 unit-dose tablets. Instructions for opening the blister pack are also depicted with illustrations showing how to tear along the perforation and peel back the labeled backing to remove the tablet.*
FDA Label Image

1 (Rizatriptan Odt Usp 10mg 3x6s Pack)

1 (Rizatriptan Odt Usp 10mg 3x6s Pack)
Packaging label for Rizatriptan Benzoate Orally Disintegrating Tablets, USP 10 mg by Macleods Pharmaceuticals Limited. The label features the product name prominently and indicates 18 tablets (3 x 6 unit-dose tablets) per package. It includes instructions for opening the blister pack and manufacturing details, with Macleods Pharma USA as the labeler.*
FDA Label Image

1 (Rizatriptan Odt Usp 10mg 3x3s Pack)

1 (Rizatriptan Odt Usp 10mg 3x3s Pack)
Packaging label for Rizatriptan Benzoate Orally Disintegrating Tablets USP 10 mg, manufactured by Macleods Pharmaceuticals Limited. The label shows a 9-tablet carton (3 x 3 unit-dose tablets) with instructions for opening the blister pack and storage information. The labeler is Macleods Pharma USA, with manufacturing in India.*
FDA Label Image

1 (Rizatriptan Odt Usp 10mg 6x3s Pack)

1 (Rizatriptan Odt Usp 10mg 6x3s Pack)
Packaging label for Rizatriptan Benzoate Orally Disintegrating Tablets USP 10 mg by Macleods Pharmaceuticals Limited. The label indicates a pack size of 18 tablets (6 x 3 unit-dose tablets). The label includes instructions for opening the blister pack, manufacturing details, and storage conditions. The package is marked Rx only with a barcode and notice about phenylalanine content for phenylketonurics.*
FDA Label Image

Atriptan-odt-usp-10mg-2x6s-pack.jpg (Rizatriptan Odt Usp 10mg 2x6s Pack)

Atriptan-odt-usp-10mg-2x6s-pack.jpg (Rizatriptan Odt Usp 10mg 2x6s Pack)
Packaging label for Rizatriptan Benzoate Orally Disintegrating Tablets, USP 10 mg by Macleods Pharmaceuticals Limited. The label includes the NDC 33342-094-45 and states the package contains 12 tablets (2 x 6 unit-dose tablets). It shows the manufacturer as Macleods Pharma USA and Macleods Pharmaceuticals Ltd. The package includes pharmacist instructions to dispense the patient information leaflet with the drug product. The label also features opening instructions for the blister pack and storage information.*
FDA Label Image

1 (Rizatriptan Odt Usp 10mg 30s Pack)

1 (Rizatriptan Odt Usp 10mg 30s Pack)
Label for Rizatriptan Benzoate Orally Disintegrating Tablets, USP 10 mg, manufactured by Macleods Pharmaceuticals Ltd. The label includes storage instructions, a note for pharmacists to dispense the patient information leaflet, and the package contains 30 tablets. It also lists the manufacturer as Macleods Pharma USA, Inc., Princeton, NJ.*
FDA Label Image

1 (Rizatriptan Odt Usp 10mg 200s Pack)

1 (Rizatriptan Odt Usp 10mg 200s Pack)
Label for Rizatriptan Benzoate Orally Disintegrating Tablets, USP 10 mg, manufactured by Macleods Pharmaceuticals Limited and labeled for Macleods Pharma USA, Inc. The label indicates 200 tablets per container, includes storage instructions, and notes that it contains phenylalanine. It displays the NDC 33342-094-46 and emphasizes pharmacist dispensing information.*
FDA Label Image

556 (Rizatriptan Odt Usp 10mg 12s Pack)

556 (Rizatriptan Odt Usp 10mg 12s Pack)
Packaging label for Rizatriptan Benzoate Orally Disintegrating Tablets USP 10 mg by Macleods Pharmaceuticals Limited. The label displays dosage strength, manufacturer information for Macleods Pharma USA and Macleods Pharmaceuticals Ltd in India, storage instructions, and a barcode. The package contains 12 tablets with a note for pharmacists to dispense the patient information leaflet.*
FDA Label Image

776 (Rizatriptan Odt Usp 10mg 18s Pack)

776 (Rizatriptan Odt Usp 10mg 18s Pack)
Packaging label for Rizatriptan Benzoate Orally Disintegrating Tablets USP 10 mg by Macleods Pharmaceuticals Limited. The label shows 18 tablets in the package with storage instructions and dosage info referencing prescription use. It includes barcodes and manufacturing details for Macleods Pharmaceuticals and Pharme USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.